Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Type 2 diabetes continues to be a serious and highly prevalent public health problem
worldwide. In 2019, the highest prevalence of diabetes in the world at 12.2%, with its …

Background Type 2 diabetes is affecting people at an increasingly younger age, particularly
in the Middle East and in north Africa. We aimed to assess whether an intensive lifestyle …

Background & Aim Non-alcoholic fatty liver disease (NAFLD) has become a major cause of
chronic liver disease (CLD) worldwide. Our aim was to assess the burden of liver …

With the increasing prevalence of obesity and type 2 diabetes, fatty liver disease associated
with metabolic dysfunction is a global health problem, especially because it is one of the …

Hypertensive heart disease (HHD) is a major cause of global morbidity and mortality.
Understanding its current burden among various countries and populations is crucial for …

Background Cardiovascular disease (CVD) is the leading cause of death in the world. In the
United Arab Emirates (UAE), it accounts for 40% of mortality. CVD is caused by multiple …

Evidence suggests that low carbohydrate (< 130 g/day of carbohydrate)(LCD) and very low
carbohydrate, ketogenic diets (typically< 50 g/day of carbohydrate)(VLCKD) can be effective …

Objective We aimed to report the most current data on the prevalence, incidence, and years
lived with disability (YLDs) associated with osteoarthritis (OA) for the 21 countries and …

The landscape of chronic liver disease in Egypt has drastically changed over the past few
decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to …